Ömer Faruk Bayrak

1.4k total citations
58 papers, 1.0k citations indexed

About

Ömer Faruk Bayrak is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Ömer Faruk Bayrak has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Cancer Research and 12 papers in Rheumatology. Recurrent topics in Ömer Faruk Bayrak's work include Bone Tumor Diagnosis and Treatments (11 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (8 papers). Ömer Faruk Bayrak is often cited by papers focused on Bone Tumor Diagnosis and Treatments (11 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (8 papers). Ömer Faruk Bayrak collaborates with scholars based in Türkiye, United States and Sweden. Ömer Faruk Bayrak's co-authors include Fikrettin Şahιn, Şükrü Güllüoğlu, Mustafa Çulha, Mehmet Kahraman, Mehmet E. Yalvaç, Emre Can Tüysüz, Uğur Türe, M. Müge Yazıcı, Albert A. Rizvanov and Mustafa Özen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Journal of Controlled Release.

In The Last Decade

Ömer Faruk Bayrak

55 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ömer Faruk Bayrak Türkiye 19 372 229 160 145 137 58 1.0k
Philipp Mayer‐Kuckuk United States 18 648 1.7× 134 0.6× 134 0.8× 259 1.8× 189 1.4× 38 1.4k
Siyu Liu China 18 667 1.8× 313 1.4× 91 0.6× 31 0.2× 93 0.7× 58 995
Gemma Di Pompo Italy 18 449 1.2× 230 1.0× 47 0.3× 51 0.4× 219 1.6× 30 905
Chenguang Zhang China 18 741 2.0× 381 1.7× 134 0.8× 165 1.1× 122 0.9× 60 1.5k
Xi Yang China 23 824 2.2× 283 1.2× 22 0.1× 101 0.7× 130 0.9× 62 1.8k
Shengyun Huang China 19 444 1.2× 179 0.8× 43 0.3× 53 0.4× 153 1.1× 74 1.1k
Joshua J. Souchek United States 16 462 1.2× 245 1.1× 79 0.5× 15 0.1× 163 1.2× 22 1.0k
David M. Lurie United States 13 149 0.4× 52 0.2× 34 0.2× 54 0.4× 52 0.4× 23 821

Countries citing papers authored by Ömer Faruk Bayrak

Since Specialization
Citations

This map shows the geographic impact of Ömer Faruk Bayrak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Faruk Bayrak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Faruk Bayrak more than expected).

Fields of papers citing papers by Ömer Faruk Bayrak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Faruk Bayrak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Faruk Bayrak. The network helps show where Ömer Faruk Bayrak may publish in the future.

Co-authorship network of co-authors of Ömer Faruk Bayrak

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer Faruk Bayrak. A scholar is included among the top collaborators of Ömer Faruk Bayrak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer Faruk Bayrak. Ömer Faruk Bayrak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bayrak, Ömer Faruk, et al.. (2025). Mitochondrial DNA depletion promotes vasculogenic properties through mesenchymal alteration in glioblastoma. Journal of Taibah University for Science. 19(1). 1 indexed citations
2.
Dalan, Altay Burak, et al.. (2025). Targeting GSTM3 for therapeutic potential in advanced prostate cancer. BMC Cancer. 25(1). 1493–1493.
3.
Dalan, Altay Burak, et al.. (2025). Connexin 43 inhibitors reduce cell viability in glioblastoma and astrocyte co-culture systems. Molecular Biology Reports. 52(1). 803–803.
4.
Özbil, Mehmet, Murat Topuzoğulları, İrfan Çınar, et al.. (2025). Phage-inspired targeting of antibiotic-loaded polymeric micelles for enhanced therapeutic efficacy against monomicrobial sepsis. Journal of Controlled Release. 380. 773–786. 1 indexed citations
5.
Acar, Tayfun, et al.. (2024). Evaluation of bacteriophage ϕ11 host recognition protein and its host-binding peptides for diagnosing/targeting Staphylococcus aureus infections. International Journal of Antimicrobial Agents. 64(2). 107230–107230. 2 indexed citations
6.
Bayrak, Ömer Faruk, et al.. (2024). Related mechanisms, current treatments, and new perspectives in meningioma. Genes Chromosomes and Cancer. 63(5). e23248–e23248. 3 indexed citations
7.
Bayrak, Ömer Faruk, et al.. (2023). Investigating the Effects of Chordoma Cell-Derived Exosomes on the Tumorigenicity of Nucleus Pulposus Cells. Journal of Neurological Surgery Part B Skull Base. 85(2). 161–167.
8.
Bayrak, Ömer Faruk, et al.. (2023). NANOG Dominates Interleukin-6-Induced Sphere Formation in Prostate Cancer. Urology Research and Practice. 49(6). 376–380. 2 indexed citations
9.
Tüysüz, Emre Can, et al.. (2023). Impact of silencing eEF2K expression on the malignant properties of chordoma. Molecular Biology Reports. 50(4). 3011–3022. 1 indexed citations
10.
Bayrak, Ömer Faruk, et al.. (2020). E-cadherin might be a stage-dependent modulator in aggressiveness in pancreatic cancer cells. TURKISH JOURNAL OF BIOLOGY. 44(5). 230–237. 1 indexed citations
11.
Bayrak, Ömer Faruk, et al.. (2019). Silencing Breast Cancer Genes Using Morpholino Embedded DNA-Tile-AuNPs Nanostructures. Human Gene Therapy. 30(12). 1547–1558. 8 indexed citations
12.
Demirci, Selami, Ayşegül Doğan, Emre Can Tüysüz, et al.. (2017). Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells. Molecular and Cellular Biochemistry. 437(1-2). 133–142. 21 indexed citations
13.
Karataş, Ömer Faruk, et al.. (2017). Characterization of stem-like cells in a new astroblastoma cell line. Experimental Cell Research. 352(2). 393–402. 3 indexed citations
14.
Başaran, Recep, Ömer Faruk Bayrak, Tuncay Kaner, et al.. (2014). The role of a single nucleotide polymorphism of the matrix metalloproteinase-1 gene promoter region in invasion and prognosis of meningiomas. Turkish Neurosurgery. 24(5). 731–6. 4 indexed citations
15.
Küçükgüzel, İlkay, Sevım Rollas, Erik De Clercq, et al.. (2014). Synthesis and evaluation of antiviral, antitubercular and anticancer activities of some novel thioureas derived from 4-aminobenzohydrazide hydrazones. DergiPark (Istanbul University). 11 indexed citations
16.
Bayrak, Ömer Faruk, et al.. (2012). Investigation of ace genome insertion/deletion correlation with immunohistochemical profile in pituitary adenomas. Turkish Neurosurgery. 23(4). 464–9. 1 indexed citations
17.
Yalvaç, Mehmet E., Murat Tekgüç, Ömer Faruk Bayrak, et al.. (2010). Human Tooth Germ Stem Cells Preserve Neuro-Protective Effects after Long-Term Cryo-Preservation. Current Neurovascular Research. 7(1). 49–58. 43 indexed citations
18.
Bayrak, Ömer Faruk, et al.. (2010). The effect of polymorphisms in the promoter region of the MMP-1 gene on the occurrence and invasiveness of hypophyseal adenoma. Acta Neurochirurgica. 152(9). 1611–1617. 19 indexed citations
19.
Karakuş, Sevgi, Ş. Güniz Küçükgüzel, İlkay Küçükgüzel, et al.. (2009). Synthesis, antiviral and anticancer activity of some novel thioureas derivedfrom N-(4-nitro-2-phenoxyphenyl)-methanesulfonamide. European Journal of Medicinal Chemistry. 44(9). 3591–3595. 52 indexed citations
20.
Akgün, Hülya, et al.. (2009). Nitric Oxide Releasing Derivatives of [(2-Chloroethyl)ureido] Benzoic Acid Esters as Potential Antineoplastic Agents. TURKISH JOURNAL OF CHEMISTRY. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipp Mayer‐Kuckuk Breakdown of academic impact, for papers by Siyu Liu Breakdown of academic impact, for papers by Gemma Di Pompo Breakdown of academic impact, for papers by Chenguang Zhang Breakdown of academic impact, for papers by Xi Yang Breakdown of academic impact, for papers by Shengyun Huang Breakdown of academic impact, for papers by Joshua J. Souchek Breakdown of academic impact, for papers by David M. Lurie
Rankless by CCL
2026